PROCEPT BioRobotics Corporation ( NASDAQ:PRCT ) just released its latest quarterly results and things are looking...
On May 1, 2024, Thomas Krummel, Director at PROCEPT BioRobotics Corp (NASDAQ:PRCT), sold 20,000 shares of the company.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript May 1, 2024 PROCEPT BioRobotics Corporation beats earnings expectations. Reported EPS is $-0.51, expectations were $-0.55. PRCT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to PROCEPT […]